• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Secondhand smoke exposure counseling may be insufficient amongst cardiology inpatients

byAnees DaudandJames Jiang
November 11, 2014
in Cardiology, Public Health
Reading Time: 3 mins read
Secondhand smoke exposure counseling may be insufficient amongst cardiology inpatients
Share on FacebookShare on TwitterShare on LinkedIn

1. Amongst non-smoking patients with coronary heart disease (CHD) admitted to the inpatient cardiology service, nearly one-half of the tested patients had evidence of a nicotine metabolite, suggesting exposure to secondhand smoke (SHS). However, less than one-fifth of the participants were actually asked about their secondhand smoke exposure history by a health care professional.

2. Although most patients agreed that SHS was dangerous to their health, there is still a significant opportunity for clinicians to address the dangers of SHS in the inpatient cardiology service.

Evidence Rating Level: 2 (Good)

Study Rundown: Second-hand smoke (SHS) is a risk factor for developing cardiovascular disease and poses a significant risk to those who have preexisting coronary heart disease (CHD). Patients admitted to the hospital with acute coronary syndrome are at higher risk for re-infarction if they are exposed to SHS after discharge. This study, which took place at the inpatient cardiology unit of Massachusetts General Hospital, was conducted to determine the opinions and medical counseling related to SHS amongst non-smoking, CHD patients. The results suggest that while close to one-half of the tested patients had evidence of a nicotine metabolite, suggesting exposure to SHS, less than one-fifth of the participants were actually asked about their SHS exposure history by a health care professional. Although most patients agreed that SHS was dangerous to their health, there is still a significant opportunity for clinicians to address the dangers of SHS in the inpatient cardiology service.

The strength of the study is the specificity of the question asked, which allowed for a simple design to be effective. However, the results are not necessarily generalizable since only one unit of a hospital was included in the study. Rather, this study allows for future investigation of this question in a larger setting.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

Click to read an invited commentary in JAMA Internal Medicine

Relevant Reading: Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults

In-Depth [cross-sectional]: The study was conducted at Massachusetts General Hospital. Inclusion criteria were adults in the inpatient cardiology service with a diagnosis of CHD on admission, no history of tobacco or nicotine use, and a stay of less than 48 hours. Eligible participants underwent a thorough demographics interview and had a saliva sample collected for assessing presence of cotinine, a nicotine metabolite that has a 16-hour half-life.

Between May 2010 and January 2011, 214 individuals participated in the study. While using the sensitive cotinine assay, 40.3% of the 72 samples tested were positive. Almost all of the patients (89.7%) believed that SHS was harmful and more than half (56.5%) believed that SHS increased non-smokers’ risk of a heart attack. However, only 17.3% remembered being asked by a clinician about their SHS exposure history.

More from this author: Dabigatran linked with more major bleeds, fewer intracranial hemorrhages vs warfarin, Non-invasive ventilation linked with lower mortality in COPD exacerbations, Cigarette smoking remains a leading cause of preventable medical problems, Beta-lactam monotherapy may be inferior to combination therapy in pneumonia, Percutaneous intervention outcomes for STEMI similar for women and men, Mechanical aortic valve replacement linked with increased early mortality

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: smoking
Previous Post

AABB guidelines for prophylactic platelet transfusions

Next Post

Dual VA and Medicare coverage linked to glucose strip overuse

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Cardiology

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

March 3, 2026
No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer
Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

April 13, 2025
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Higher nicotine consumption observed among youth with attention-deficit hyperactivity disorder

May 19, 2025
Next Post
Dual VA and Medicare coverage linked to glucose strip overuse

Dual VA and Medicare coverage linked to glucose strip overuse

Hospice associated with reduced healthcare utilization in cancer patients

Classics Series, Landmark Trials in Medicine

Cerclage prevents recurrent preterm birth in women with short cervix [Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer
  • Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants
  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer in interim phase 3 results
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.